Melbourne, Australia: Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is one of two healthcare companies presenting at the Macquarie Bank Australia and New Zealand Annual Corporate Day in Hong Kong and Singapore.

Commencing today, the presentation to institutional investors from the Asia region will include 33 companies from Australia, from either the top 50 or 200 ASX listed companies.  Starpharma and Mesoblast are the only two healthcare companies invited to present.  Other companies include Amcor, Computershare, Oil Search and Westfield.

Starpharma’s investment profile continues to grow in the region with a number of Asian funds now on the share register.  Starpharma Chief Executive Officer Dr Jackie Fairley will also meet with a number of funds including several existing Asian institutional investors during her visit to the region.

Dr Fairley’s presentation will detail recent developments in Starpharma’s clinical trial program including progress with VivaGel^® as both a treatment and preventative product for bacterial vaginosis, partnering activities including the recent deal with Ansell, and development plans for new internal programs including agrochemicals and drug delivery.

Download ASX Announcement & Presentation: Starpharma presents at Macquarie investor event (pdf file, 2MB)